Combination Antibiotics - Co-Trimoxazole, Co-Amoxiclav, Quinupristin-Dalfopristin, Imipenem-Cilastatin, Co-Fluampicil, Ampicillin-Sulbactam (Paperback)


Chapters: Co-Trimoxazole, Co-Amoxiclav, Quinupristin/dalfopristin, Imipenem/cilastatin, Co-Fluampicil, Ampicillin/sulbactam, Synulox, Piperacillin/tazobactam, Penimepicycline, Panipenem/betamipron, Pantopac. Source: Wikipedia. Pages: 37. Not illustrated. Free updates online. Purchase includes a free trial membership in the publisher's book club where you can select from more than a million books without charge. Excerpt: Co-trimoxazole (abbreviated SXT, TMP-SMX, TMP-SMZ or TMP-sulfa) is a sulfonamide antibiotic combination of trimethoprim and sulfamethoxazole, in the ratio of 1 to 5, used in the treatment of a variety of bacterial infections. The name co-trimoxazole is the British Approved Name, and has been marketed worldwide under many trade names including Septra (GSK), Bactrim (Roche), and various generic preparations. Sources differ as to whether co-trimoxazole usually is bactericidal or bacteriostatic. The synergy between trimethoprim and sulphamethoxazole was first described in a series of in vitro and in vivo experiments published in the last 1960's. Trimethoprim and sulfamethoxazole have a greater effect when given together than when given separately; the reasons is because they inhibit successive steps in the folate synthesis pathway (see diagram below). It is unclear whether this synergy occurs at doses used in humans, because at the concentrations seen in blood and tissues, the ratio of trimethoprim to sulphamethoxazole is 1:20, which is less than the 1:5 ratio needed in vitro for synergy to occur. Sulfamethoxazole acts as a false-substrate inhibitor of dihydropteroate synthetase. Sulfonamides such as sulfamethoxazole are analogues of p-aminobenzoic acid (PABA) and are competitive inhibitors of the enzyme; inhibiting the production of dihydropteroic acid. Trimethoprim acts by interfering with the action of bacterial dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Folic acid is an essential p...More: http: //booksllc.net/?id=99563

R350

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles3500
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

Chapters: Co-Trimoxazole, Co-Amoxiclav, Quinupristin/dalfopristin, Imipenem/cilastatin, Co-Fluampicil, Ampicillin/sulbactam, Synulox, Piperacillin/tazobactam, Penimepicycline, Panipenem/betamipron, Pantopac. Source: Wikipedia. Pages: 37. Not illustrated. Free updates online. Purchase includes a free trial membership in the publisher's book club where you can select from more than a million books without charge. Excerpt: Co-trimoxazole (abbreviated SXT, TMP-SMX, TMP-SMZ or TMP-sulfa) is a sulfonamide antibiotic combination of trimethoprim and sulfamethoxazole, in the ratio of 1 to 5, used in the treatment of a variety of bacterial infections. The name co-trimoxazole is the British Approved Name, and has been marketed worldwide under many trade names including Septra (GSK), Bactrim (Roche), and various generic preparations. Sources differ as to whether co-trimoxazole usually is bactericidal or bacteriostatic. The synergy between trimethoprim and sulphamethoxazole was first described in a series of in vitro and in vivo experiments published in the last 1960's. Trimethoprim and sulfamethoxazole have a greater effect when given together than when given separately; the reasons is because they inhibit successive steps in the folate synthesis pathway (see diagram below). It is unclear whether this synergy occurs at doses used in humans, because at the concentrations seen in blood and tissues, the ratio of trimethoprim to sulphamethoxazole is 1:20, which is less than the 1:5 ratio needed in vitro for synergy to occur. Sulfamethoxazole acts as a false-substrate inhibitor of dihydropteroate synthetase. Sulfonamides such as sulfamethoxazole are analogues of p-aminobenzoic acid (PABA) and are competitive inhibitors of the enzyme; inhibiting the production of dihydropteroic acid. Trimethoprim acts by interfering with the action of bacterial dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Folic acid is an essential p...More: http: //booksllc.net/?id=99563

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Books + Company

Country of origin

United States

Release date

September 2010

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

September 2010

Editors

Creators

Dimensions

152 x 229 x 2mm (L x W x T)

Format

Paperback - Trade

Pages

38

ISBN-13

978-1-157-48771-5

Barcode

9781157487715

Categories

LSN

1-157-48771-8



Trending On Loot